Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Inverkan av hälsoinformation på kunskap, attityd och praxis vid postexpositionsprofylax

12 november 2026 uppdaterad av: Fatma Ali Mahmoud Hussein, Aswan University

Effekten av hälsofrämjande undervisning på kunskap, attityd och praxis av postexpositionsprofylax bland vårdpersonal på Aswan University Hospital, Egypten

The goal of this study is to learn whether a short education programme helps healthcare workers know more about post-exposure prophylaxis (PEP). PEP is medicine taken soon after contact with blood or body fluids, to lower the chance of infection. The study takes place at Aswan University Hospital in Egypt.

The main questions it aims to answer are:

Do healthcare workers know more about PEP three months after the programme than before it?

Do their attitudes toward PEP change?

Do their reported actions change, such as hepatitis B vaccination, use of PEP after an exposure, and finishing the prescribed course?

Participants are doctors, nurses, and laboratory and blood bank staff who work with patients or blood samples. They will:

Fill out a questionnaire before the programme.

Attend four 2-hour teaching sessions over two weeks.

Fill out the same questionnaire about three months later.

All participants receive the programme. There is no comparison group. Researchers will compare each person's answers before and after the programme to see what changed.

Studieöversikt

Detaljerad beskrivning

Design. This is a single-group, before-and-after (quasi-experimental) study. Each participant completes a baseline questionnaire before teaching and a follow-up questionnaire about three months after their group finishes teaching. Coded identifiers link the two questionnaires. The study ran from 30 January 2026 to 30 June 2026.

Setting and participants. The study took place at Aswan University Hospital in southern Upper Egypt. Staff were selected by stratified random sampling from three groups: physicians and clinically active academic staff, nurses, and laboratory and blood bank staff. Workers had to be actively employed in one of these groups, have worked at the hospital for at least six months, and give written informed consent. Non-clinical, housekeeping and auxiliary staff were excluded. In total, 380 workers were selected, and the target was 340 with complete before-and-after data.

Intervention. The programme had four 2-hour sessions over two weeks. Topics were:

Recognising and reporting an exposure.

First aid.

Assessing the source patient and the exposure.

Access to PEP in the hospital.

Hepatitis B vaccination.

HIV PEP timing and duration.

Adherence, counselling and follow-up testing.

The programme also covered the difference between HIV prophylaxis, hepatitis B prevention and hepatitis C follow-up. Teaching used slides, short videos, case scenarios, group discussion and printed materials. Physicians were taught in English, and nurses and laboratory staff in Arabic.

Measures. A questionnaire, adapted from published PEP surveys and available in Arabic and English, was used at both time points.

Primary outcome: change in a five-item knowledge score (0-5), calculated as follow-up score minus baseline score.

Secondary outcomes: change in a seven-item attitude and belief score (0-7), and individual practice indicators. These are self-reported hepatitis B vaccination, PEP use after exposure, time to starting PEP, and completion of the prescribed course.

Analysis. Paired changes are tested with the Wilcoxon signed-rank test for scores and the exact McNemar test for yes/no responses. Confidence intervals are reported for paired differences. The sample size was calculated to estimate a proportion with 5% precision, not to detect a difference between paired groups.

Changes from the original registration. The original record described nine knowledge questions and threshold-based classifications of knowledge, attitude and practice. The final analysis uses a five-item knowledge score, a seven-item attitude total without an overall classification, and individual practice indicators. The dates were updated to the actual start (30 January 2026) and completion (30 June 2026).

Studietyp

Interventionell

Inskrivning (Faktisk)

340

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Aswān, Egypten
        • Aswan faculty of Medicine

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

19 år till 55 år (Vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  1. HCWs at the selected departments (physicians, nurses and housekeepers).
  2. Age >18 years old and below 60 years old in both Genders.
  3. HCWs which have direct contact with blood and body fluids.

Exclusion Criteria:

  1. Age<18 years old and above 60 years old.
  2. Non-medical staff at Aswan university hospital.
  3. Health care workers which have no contact with blood or body fluids.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Health Care workers

About 340 participants of heath care workers undergoing assessment of knowledge, attitude and practice about post-exposure prophylaxis among health care workers at Aswan university hospital, Egypt Then they will undergo lecturers about about post-exposure prophylaxis, then reassessment will be done after 3 months

  1. Assess the baseline knowledge, attitudes and practices of health care workers at Aswan university hospital towards postexposure prophylaxis against blood-borne viral infection.
  2. Provide an intense post exposure prophylaxis health education sessions.
  3. Evaluate changes in post exposure prophylaxis knowledge, attitudes and practices after the health education intervention.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Health Practice Change
Tidsram: 3 Months

Assessment of participants after taking health education lecturers about post-exposure prophylaxis regrading to knowledge, attitude and practice and this done by questionnaire as :The questionnaire consisted of three sections assessing knowledge, attitude, and practice regarding post-exposure prophylaxis (PEP).

Section B assessed knowledge using nine close-ended questions, with adequate knowledge defined as ≥75% correct answers.

Section C included seven items evaluating attitudes toward the importance and effectiveness of PEP, with scores ≥75% indicating a good attitude.

Section D assessed PEP practices through nine questions, and good practice was defined as positive responses to more than 75% of items.

3 Months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Studiestol: Shaimaa Sayed Abdelrheem, M.D, Associate Professor of Public Health and Community Medicine, Faculty of medicine, Aswan University

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

30 januari 2026

Primärt slutförande (Faktisk)

30 juni 2026

Avslutad studie (Faktisk)

30 juni 2026

Studieregistreringsdatum

Först inskickad

11 december 2025

Först inskickad som uppfyllde QC-kriterierna

4 januari 2026

Första postat (Faktisk)

9 januari 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

12 november 2026

Senast verifierad

1 januari 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

OBESLUTSAM

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera